Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term ...

Globus Medical’s first quarter results were impacted by a mix of operational headwinds, with management pointing to softer ...

Piper Sandler noted some "unwanted dislocation" at Globus Medical but characterized these issues as "manageable," indicating that the Nevro deal is not currently "imploding" despite market concerns.

Get the latest Globus Medical, Inc. (GMED) stock news and headlines to help you in your trading and investing decisions.

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

Globus Medical specializes in spine, trauma, and robotic technologies. In April, the company completed its $250 million acquisition of Nevro Corp, a life sciences firm based in California.

Globus Medical P/E Ratio Analysis in Relation to Industry Peers The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's ...

Globus Medical Short Interest Graph (3 Months) As you can see from the chart above the percentage of shares that are sold short for Globus Medical has grown since its last report.

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors are advised to ...